Filtered By:
Source: European Review for Medical and Pharmacological Sciences
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 32866 results found since Jan 2013.
Effectiveness and safety of cabazitaxel chemotherapy for metastatic castration-resistant prostatic carcinoma on Turkish patients (The Anatolian Society of Medical Oncology).
CONCLUSIONS: This study reflects toxicity profile of Turkish patients as a Caucasian race. We suggest that cabazitaxel is a safe and effective treatment option for mCRPC patients who progress after docetaxel. Moreover, ethnicity may play important roles both in treatment response and in toxicity profile.
PMID: 27097941 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - April 23, 2016 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Comment on "The static evolution of the new Italian code of medical ethics".
Authors: Ricci G, Vitali M, Tambone V
PMID: 27424970 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - July 21, 2016 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
New boundaries of prescription: focus on section 13 of the new Italian code of medical ethics.
Authors: Papi M, Giorgetti R, Tagliabracci A
PMID: 27424969 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - July 21, 2016 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Comment on "The static evolution of the new Italian code of medical ethics".
Authors: Cecchi R
PMID: 27424968 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - July 21, 2016 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Evaluation of medical prescriptions and off-label use on board ships to improve healthcare quality.
CONCLUSIONS: The results suggest that a standardization of onboard pharmacies is crucial, in order to have a complete on-board pharmacy that will allow preventing and counteracting any situation of health danger, which may occur onboard, ensuring high quality healthcare to seafarers all over the world.
PMID: 30024631 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - July 20, 2018 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Short Report - Medical nutrition therapy for critically ill patients with COVID-19.
Authors: Romano L, Bilotta F, Dauri M, Macheda S, Pujia A, De Santis GL, Tarsitano MG, Merra G, Di Renzo L, Esposito E, De Lorenzo A
Abstract
No Abstract Available.
PMID: 32329880 [PubMed - as supplied by publisher]
Source: European Review for Medical and Pharmacological Sciences - April 26, 2020 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Assisted suicide: article 17 of the Italian Code of Medical Ethics follows in the footsteps of the Italian Constitutional Court's landmark ruling.
Authors: Marinelli E, Busardò FP
PMID: 33155257 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - November 10, 2020 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
Potential drug-drug interactions in University Hospital Medical Intensive Care Unit patients in Turkey
CONCLUSIONS: Use of frequently interacting drugs in the treatment of critically MICU patients may lead to potential drug-drug interactions and adverse reactions. Daily monitoring and updating of drug therapy can improve patient's quality of life by preventing or reducing potential drug-drug interactions.PMID:34859876 | DOI:10.26355/eurrev_202111_27264
Source: European Review for Medical and Pharmacological Sciences - December 3, 2021 Category: Drugs & Pharmacology Authors: M Jafarova Demirkapu S Pinar Kara Source Type: research
Awareness and obscurity: demystifying genomic profiling in real-world practice for the members of the Turkish Society of Medical Oncology (TSMO)
CONCLUSIONS: Several informational difficulties must be resolved in order to have early personalized therapy as the standard treatment. We need accessible, comprehensive, and regularly updated databases to compare genetic profiling and its therapeutic implications. We also need to continue educating patients and physicians.PMID:37203840 | DOI:10.26355/eurrev_202305_32323
Source: European Review for Medical and Pharmacological Sciences - May 19, 2023 Category: Drugs & Pharmacology Authors: E Bayram B Sahin Source Type: research
